Drug recall · June 4, 2014
Metoprolol Succinate Extended-Release Tablets recall
Why: Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle, Rx only. Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC., 20 Water view Blvd., Parsippany, NJ 07054, USA. NDC: 64679-736-02.
- Lots / codes
Lot #: LN11423, Expiry: 8/15/15
- Quantity
- 8712 Bottles
- Company
- Wockhardt Usa Inc., Parsippany, NJ
- Distribution
- Nationwide.
- Initiated
- April 10, 2014 · Voluntary: Firm initiated
- Classified
- May 29, 2014
- Reported
- June 4, 2014
- Ended
- August 13, 2015
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoprolol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.